Elevated Glucagon-like Peptide-1 and a Th2 Shift May Support Reduced Prevalence of Thoracic Aortic Aneurysm in Patients with Diabetes

Glucagon-like peptide-1 (GLP-1) regulates processes involved in the pathophysiology of thoracic aortic aneurysms (TAAs), including inflammation, while protecting against aortic aneurysms in animal models. Type 2 diabetes (T2D) involves altered GLP-1 signaling due to pathology and/or therapy and is associated with reduced prevalence of TAAs. We aimed to assess whether T2D alters the inflammatory profile/proteolytic activity, possible correlations to elevated fasting GLP-1 (F-GLP-1), and its relevance for TAA. F-GLP-1, pro-inflammatory T helper 1 (Th1) cytokines, Th2 cytokines, C-reactive protein, and matrix metalloproteinase-2 activity (MMP-2) were analyzed in surgical patients with aortic valve pathology with/without T2D and without T2D but with TAA. Patients with T2D displayed an increase in the relative systemic expression of interleukin 6 and tumor necrosis factor α and a clear trend towards reduced levels of interferon γ (IFNγ). In addition, a positive association between GLP-1 and the plasma interleukin 4 (IL-4)/IFNγ ratio was detected. TAA was associated with significantly lower plasma levels of the Th2 cytokines IL-4 and interleukin 5. Plasma MMP-2 activity did not differ between groups. We conclude that T2D involved a Th2 shift, which associates with elevated F-GLP-1 and may—considering Th1 bias in TAA—contribute to reduced prevalence of TAA in T2D.

• Publication year

  2021

• Venue

  Journal of Cardiovascular Development and Disease

• Publication date

  2021-10-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/jcdd8110143PMID 34821696PMCID 8618274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes, Incretin therapy and thoracic aortic aneurysm-what does the evidence show?

  2019cited by this paper
• Glucagon-like peptide 1 (GLP-1)

  2019cited by this paper
• Reduced Long‐Term Risk of Aortic Aneurysm and Aortic Dissection Among Individuals With Type 2 Diabetes Mellitus: A Nationwide Observational Study

  2018cited by this paper
• Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.

  2018cited by this paper
• IL-1&bgr; (Interleukin-1&bgr;) and TNF-&agr; (Tumor Necrosis Factor-&agr;) Impact Abdominal Aortic Aneurysm Formation by Differential Effects on Macrophage Polarization

  2018cited by this paper
• Obesity-Induced TNFα and IL-6 Signaling: The Missing Link between Obesity and Inflammation—Driven Liver and Colorectal Cancers

  2018cited by this paper
• Glucagon-Like peptide-1: A new therapeutic target to treat abdominal aortic aneurysm?

  2018cited by this paper
• Elevated circulating fasting glucagon-like peptide-1 in surgical patients with aortic valve disease and diabetes

  2017cited by this paper
• Hereditary Influence in Thoracic Aortic Aneurysm and Dissection.

  2016cited by this paper
• Advanced complicated diabetes mellitus is associated with a reduced risk of thoracic and abdominal aortic aneurysm rupture: a population‐based cohort study

  2015cited by this paper
• Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System

  2015cited by this paper
• Responses of GLP1-secreting L-cells to cytotoxicity resemble pancreatic β-cells but not α-cells.

  2015cited by this paper
• Risk Profiles for Aortic Dissection and Ruptured or Surgically Treated Aneurysms: A Prospective Cohort Study

  2015cited by this paper
• Sirtuin 6 Expression and Inflammatory Activity in Diabetic Atherosclerotic Plaques: Effects of Incretin Treatment

  2014cited by this paper
• Baseline Levels and Temporal Stability of 27 Multiplexed Serum Cytokine Concentrations in Healthy Subjects

  2013cited by this paper
• Cytokine Levels in the Serum of Healthy Subjects

  2013cited by this paper
• Elevated plasma GLP-1 levels and enhanced expression of cardiac GLP-1 receptors as markers of left ventricular systolic dysfunction: a cross-sectional study

  2013cited by this paper
• Diabetes and Reduced Risk for Thoracic Aortic Aneurysms and Dissections: A Nationwide Case-Control Study

  2012cited by this paper
• The predictive value of TNF-α and IL-6 and the incidence of macrovascular complications in patients with type 2 diabetes

  2012influential reference
• Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects.

  2012cited by this paper
• Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia

  2011cited by this paper
• Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays

  2011cited by this paper
• Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells

  2010cited by this paper
• Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling.

  2009cited by this paper
• Inflammatory cytokines in vascular dysfunction and vascular disease.

  2009cited by this paper
• Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients

  2008cited by this paper
• Comparison of MMP‐2 and MMP‐9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages

  2008cited by this paper
• Cytokines, Inflammation, and Pain

  2007cited by this paper
• Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans.

  2006cited by this paper
• Transmural inflammation by interferon-gamma-producing T cells correlates with outward vascular remodeling and intimal expansion of ascending thoracic aortic aneurysms.

  2006cited by this paper
• Cytokines and cardiovascular disease

  2005cited by this paper
• Influence of atopic heredity on IL‐4‐, IL‐12‐ and IFN‐γ‐producing cells in in vitro activated cord blood mononuclear cells

  2001cited by this paper
• Cytokines as Plasma Markers of Abdominal Aortic Aneurysm

  2000cited by this paper
• Th1 and Th2 responses: what are they?

  2000cited by this paper
• Variables That Affect Assays for Plasma Cytokines and Soluble Activation Markers

  1999cited by this paper
• Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm.

  1997cited by this paper

• Advancements in the study of T lymphocytes in thoracic aortic aneurysm and aortic dissection.

  2025cites this paper
• Electrophysiological evidence for the right atrioventricular pacemaker ring in the reptile heart

  2025cites this paper
• Beyond Glycemic Control: Glucagon-Like Peptide-1 Receptor Agonists as Potential Modifiers of Aortic Disease.

  2025cites this paper
• Integrating Bulk Transcriptome and Single-Cell RNA Sequencing Data Reveals the Landscape of the Immune Microenvironment in Thoracic Aortic Aneurysms

  2022cites this paper